Insider Shareholders with Direct Ownership of Structure Therapeutics Inc. (GPCR)
This section provides a comprehensive overview of the insiders with direct ownership of Structure Therapeutics Inc. (GPCR). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Structure Therapeutics Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Jun Yoon
CHIEF FINANCIAL OFFICER |
269,241 | 13,029 | 1,319,876 | 5 |
Jul 01, 2025
Reduced 0.53%
|
|
Raymond C Stevens
CHIEF EXECUTIVE OFFICER |
714,711 | 583,545 | 1,194,830 | 7 |
Jul 01, 2025
Reduced 1.33%
|
|
Crespo Blas Coll
CHIEF MEDICAL OFFICER |
215,580 | 2,667 | 224,913 | 5 |
Jul 01, 2025
Reduced 0.63%
|
|
Xichen Lin
CHIEF SCIENTIFIC OFFICER |
329,814 | 112,641 | 217,173 | 6 |
Jul 01, 2025
Added 20.81%
|
|
Yingli Ma
CHIEF TECHNOLOGY OFFICER |
124,998 | 1,824 | 123,174 | 4 |
Jul 01, 2025
Added 16.57%
|
|
Ashley Hall
Chief Development Officer |
118,338 | 0 | 118,338 | 2 |
Mar 15, 2025
Added 30.14%
|
|
Mark Allen Bach
CHIEF MEDICAL OFFICER |
26,235 | 0 | 26,235 | 1 |
Mar 15, 2024
Added 50.0%
|
|
Bvf Partners L P
> 10% Shareholder |
0 | 7,410,518 | 0 | 1 |
May 10, 2023
Reduced 100.0%
|